Drug Availability

 

HPS Pharmacies wish to advise that notice has been received of a potential disruption to national supplies from the following pharmaceutical companies:

Abbotts (BGP) Eli-Lilly Phebra
Amgen Hospira Pfizer
AstraZeneca iNova Sandoz
Beiersdorf (BDF) Janssen-Cilag Sanofi
Covidien Novartis Siemens

 

These disruptions are due to various warehouses suffering hail and flood damage as a result of severe weather conditions experienced in New South Wales recently.

Furthermore, the major distribution centre of DHL in Huntingwood was also severely damaged, which may impact on the efficiency of order deliveries.

HPS Pharmacies, the manufacturers, wholesalers, and distribution networks are working to ensure that the impact of any disruptions are minimised. In the interim, HPS Pharmacies may offer alternative products to meet the therapeutic needs of patients.

Please retain this notice in a prominent position, including in other related business units for one month or until supplies return to normal.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies.

Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates